Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Atrial Fibrillation Treatment Strategy

NCT04092621 is registered in ClinicalTrials.gov with Our Lady of the Lake Hospital as lead sponsor.

NCT NCT04092621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04092621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Atrial Fibrillation Treatment Strategy
Lead sponsor
Our Lady of the Lake Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 16, 2019
Completion date
September 15, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new onset atrial fibrillation, respiratory failure, sepsis